About a third of the respondents said such partnerships will likely lead to full-blown merger and acquisition activity, as such transactions might allow greater access to technology innovation as well as widen the gene pool for talented employees, according to Mercer’s “2023 Executive Outlook Study.”
“The fact that 46 percent of executives surveyed plan to increase strategic partnerships if faced with a deepening recession suggests that successful innovation strategies recognize the availability of talent outside the permanent workforce,” the report said. “Such strategies also encourage the emergence of ecosystems to share talent and skills between organizations.”
Such findings in part echo the conclusions of a Kaufman Hall report focused on specific M&A within the healthcare industry.
While healthcare systems will face stronger rationales for M&A or strategic partnerships purely because of financial pressures, the need to innovate technologically and recruit superior talent along the way will also be a driving factor, that report said.
“One thing that is abundantly clear is that if there was ever a time to innovate, it is now — in talent and operational models,” Mercer’s report concluded.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
